Feasibility of Action Observation and Repetitive Task Practice on Upper Extremity Outcomes in Chronic Stroke Survivors

Sponsor
Ohio State University (Other)
Overall Status
Completed
CT.gov ID
NCT04015271
Collaborator
(none)
15
1
2
6.1
2.4

Study Details

Study Description

Brief Summary

The objective of this pilot randomized controlled single blinded, parallel-group study is to detect change of the Action Observation (AO) and Repetitive Task Practice (RTP) combined practice schedule on upper limb motor impairment outcomes in chronic, moderately impaired stroke survivors.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Action Observation + Repetitive Task Practice
  • Behavioral: Placebo Video + Repetitive Task Practice
N/A

Detailed Description

The current proposal aims to conduct a pilot randomized controlled single blinded, parallel-group study design to detect change of the Action Observation (AO) and Repetitive Task Practice (RTP) combined practice schedule on upper limb (UL) motor impairment outcomes in the chronic, moderately impaired stroke survivor. Individuals will be randomized to 1) experimental conditions of AO + RTP practice schedule, or 2) control condition of Placebo Video (PV) + RTP, and will receive an assigned regimen from a blinded intervention therapist for one hour, 3 times per week, for 8 weeks (total of 24 sessions), and a daily 30 minute HEP. A blinded assessor will complete assessments on each subject at three distinct time points of pretest, post intervention, and 1 month post intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A pilot randomized controlled single blinded, parallel-group study designA pilot randomized controlled single blinded, parallel-group study design
Masking:
Double (Care Provider, Outcomes Assessor)
Masking Description:
The care provider completing intervention and the outcomes assessor are members of the research team and blinded to group assignment.
Primary Purpose:
Treatment
Official Title:
The Feasibility of Action Observation and Repetitive Task Practice Combined Practice Schedule on Upper Extremity Outcomes in Moderately Impaired Chronic Stroke Survivors
Actual Study Start Date :
Jun 27, 2019
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Action Observation + Repetitive Task Practice

Action Observation (AO) therapy regimen will include watching a 6 minute video of another person completing a specified functional task (Putting on a shirt, pick up a sandwich and bring to mouth, eat food with a spoon, or cut meat with knife and fork). Subjects will be instructed to carefully watch the AO video and prepare to physically perform the task immediately after observing the video. The Repetitive Task Practice (RTP) therapy regimen emphasizes repeated physical performance with the hemiplegic upper limb for 24 minutes of a specified functional task that is matched to the AO recording. The AO + RTP regimens will be repeated for a total of 60 minutes. Each Subject will complete a Home Exercise Program (HEP) will include practicing components and movement patterns of the functional task that was difficult for the patient to perform during RTP intervention for 30 minutes each day outside of scheduled intervention sessions.

Behavioral: Action Observation + Repetitive Task Practice
Observing a video of another person performing a functional task and physically repetitively performing the same task for upper extremity hemiparesis

Placebo Comparator: Placebo Video + Repetitive Task Practice

The control placebo videos (PV) will be 6 minutes, and will include a series of changing static images without animals, human beings, or sound (i.e. pictures of buildings, trees, cruise ships, mountains, beach umbrellas, beds, and tables). A Repetitive Task Practice (RTP) therapy regimen will be completed immediately after observing the PV, which emphasizes repeated physical performance with the hemiplegic upper limb for 24 minutes of a specified functional task. These tasks include putting on a shirt, picking up a sandwich and bringing it to mouth, eating food with a spoon, or cutting meat with knife and fork. The PV + RTP regimens will be repeated for a total of 60 minutes. Each Subject will complete a Home Exercise Program (HEP) will include practicing components and movement patterns of the functional task that was difficult for the patient to perform during RTP intervention for 30 minutes each day outside of scheduled intervention sessions.

Behavioral: Placebo Video + Repetitive Task Practice
Observing a video of static images and physically repetitively performing functional task for upper extremity hemiparesis

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline in Upper extremity section of the Fugl-Meyer Scale [Pretest, immediately after the intervention, and 1 month post intervention]

    Assessment to evaluate motor impairment of the hemiplegic upper limb. Multiple time points will be used to asses the change in motor impairment. Items are scored on a 3 point ordinal scale (0 = cannot perform, 2 = can perform fully), and are totaled for a maximum of 66 possible points.

Secondary Outcome Measures

  1. Change from Baseline in the The Arm Motor Ability Test [Pretest, immediately after the intervention, and 1 month post intervention]

    Assessment to evaluate function during activities of daily living of the hemiplegic upper limb

  2. Change from Baseline in the Motor Activity Log [Pretest, immediately after the intervention, and 1 month post intervention]

    Assessment to evaluate the activity limitation of hemiplegic upper limb functional use in the community

  3. Change from baseline in smoothness of movements measured by three-axis accelerometer [Each session (3 times per week) during 8 week intervention]

    A Fitbit will be used to quantify the amount of upper limb motor activity during an intervention session and heart rate

  4. Change from Baseline in Stroke Impact Scale 2.0 [Pretest, immediately after the intervention, and 1 month post intervention]

    Assessment to evaluate motor and functional changes in the hemiplegic upper. It is a 64-item self-report measure assessing 8 domains (strength, hand function, ADL/IADL, mobility, communication, emotion, memory and thinking, and participation).A low score indicates a high impact on quality of life.

  5. Survey to assess subjects experience in the study [immediately after the intervention, and 1 month post intervention]

    A survey to examine the perceived experience of the intervention for subjects participating in the study. Subjects will answer on a 5 point ordinal scale (1 = Strongly disagree, 5 = Strongly Agree), and open ended questions will be descriptive questions to explain response on ordinal scale.

  6. Daily Diary [Each day during 8 week intervention]

    A diary to measure everyday application of functional tasks learned in the protocol and compliance with HEP

  7. Number of trials/ repetitions per task [Each session (3 times per week) during 8 week intervention]

    Measurement of the number of times a subject completes a task in a one hour session

  8. Change in Movement time to complete task [Each session (3 times per week) during 8 week intervention]

    Measure the amount of time required for a subject to complete a task during performance of task

  9. Change in Amount of physical assist to perform task [Each session (3 times per week) during 8 week intervention]

    Measure how much assistance a subject requires to complete a task. Amount will be measured in the categories of tactile cue, 1 hand assistance, 2 hand assistance

  10. Change in Number of verbal cues given to perform task [Each session (3 times per week) during 8 week intervention]

    Measure the number of verbal cues that are required for a subject to perform a task

  11. Change in the number of errors during task performance [Each session (3 times per week) during 8 week intervention]

    Measure the number of errors that a subject demonstrates while performing a task

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Experienced a stroke resulting in a Upper Extremity Fugl Meyer score >17 < 49

  • Experienced a post stroke > 6 months

  • 24 on the Folstein Mini Mental Status Examination

  • Experienced only one stroke

  • Discharged from all forms of physical rehabilitation intervention

  • Visual acuity of 20/50 or greater with or without corrective lenses

  • 19 on the Hooper Visual Organization Test

  • Unilateral stroke only

  • Cerebral stroke

  • Age of onset of stroke greater than 18 years old.

Exclusion Criteria:
  • < 18 years old

  • 5 on a 10-point visual analog pain scale in the affected UL

  • 2 on the Modified Ashworth Scale in the affected UL to exclude individuals with hypertonia, spasticity, joint rigidity, and joint contracture

  • Participating in any experimental rehabilitation or drug studies

  • Uncontrolled cardiovascular, or pulmonary disease, or other disease that would preclude involvement in a therapeutic treatment

  • Neurological disorder other than stroke

  • 31 on Beck Depression Inventory ("Severe Depression")

  • Unable to regularly attend treatment sessions and follow-up due to distance from the center or inadequate social support

  • Cerebellar stroke with ataxia

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Ohio State University Columbus Ohio United States 43210

Sponsors and Collaborators

  • Ohio State University

Investigators

  • Principal Investigator: John Buford, PhD, Ohio State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
John Buford, PT, PhD, Professor and Director of Physical Therapy Division, School of Health and Rehabilitation Sciences, Ohio State University
ClinicalTrials.gov Identifier:
NCT04015271
Other Study ID Numbers:
  • 2019H0197
First Posted:
Jul 10, 2019
Last Update Posted:
Mar 4, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by John Buford, PT, PhD, Professor and Director of Physical Therapy Division, School of Health and Rehabilitation Sciences, Ohio State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 4, 2020